Autoimmune myocarditis, valvulitis, and cardiomyopathy

Current Protocols in Immunology

Volumn , Issue SUPPL.101, 2013, Pages

  Myers, Jennifer M ^a   Fairweather, DeLisa ^b   Huber, Sally A ^c   Cunningham, Madeleine W ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Autoimmunity; Cardiac myosin; Coxsackievirus; Myocarditis; Rheumatic fever

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BICARBONATE; CARBONIC ACID; CARDIAC MYOSIN; CITRIC ACID; COMPLEMENTARY DNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIETHANOLAMINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; METHYLCELLULOSE; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; PERTUSSIS TOXIN; TROPONIN I; TROPONIN T;

ACTIVE IMMUNIZATION; ANIMAL HOUSING; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; CELL ISOLATION; CELL STIMULATION; CLINICAL PROTOCOL; COXSACKIE VIRUS B3; EMULSION; ENZYME ACTIVATION; ENZYME ASSAY; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; EXPERIMENTAL MODEL; FEMALE; HEART MUSCLE CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; MOUSE; MYOCARDITIS; NONHUMAN; PEPTIDE SYNTHESIS; PLAQUE FORMING CELL; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PURIFICATION; RAT; SPLEEN CELL; STRATEGIC PLANNING; T LYMPHOCYTE; TISSUE HOMOGENATE; VALVULAR HEART DISEASE; VALVULITIS; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALIA; COXSACKIEVIRUS; RATTUS;

EID: 84883212083     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1514s101     Document Type: Article

References (133)

1. Abston, E.D., Coronado, M.J., Bucek, A., Bedja, D., Shin, J., Kim, J.B., Kim, E., Gabrielson, K.L., Georgakopoulos, D., Mitzner, W., and Fairweather, D. 2012a. Th2 regulation of viral myocarditis in mice: Different roles for TLR3 versus TRIF in progression to chronic disease. Clin. Dev. Immunol. 2012:129486.
2. Abston, E.D., Barin, J.G., Cihakova, D., Bucek, A., Coronado, M.J., Brandt, J.E., Bedja, D., Kim, J.B., Georgakopoulos, D., Gabrielson, K.L., Mitzner, W., and Fairweather, D. 2012b. IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. Circ. Heart Fail. 5:366-375.
3. Adams, J.E.,Abendschein, D.R. 3rd, and Jaffe,A.S. 1993. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s Circulation 88:750-763.
4. Afanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, M.J., Schofield, B.H., Hill, S.L., and Rose, N.R. 2001. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am. J. Pathol. 159:193-203.
5. Afanasyeva,M., Georgakopoulos,D., Belardi, D.F., Bedja, D., Fairweather, D., Wang, Y., Kaya, Z., Gabrielson, K.L., Rodriguez, E.R., Caturegli, P., Kass, D.A., and Rose, N.R. 2005. Impaired upregulation of CD25 on CD4+ T cells in IFNgamma knockout mice is associated with progression of myocarditis to heart failure. Proc. Natl. Acad. Sci. U.S.A. 102:180-185.
6. Aretz, H.T. 1987. Myocarditis: The Dallas criteria. Hum. Pathol. 18:619-624.
7. Aretz, H.T., Billingham, M.E., Edwards, W.D., Factor, S.M., Fallon, J.T., Fenoglio, J.J. Jr., Olsen, E.G., and Schoen, F.J. 1987. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1:3-14.
8. Bachmaier, K., Mair, J., Offner, F., Pummerer, C., and Neu, N. 1995. Serum cardiac troponin T and creatine kinase-MB elevations in murine autoimmune myocarditis. Circulation 92:1927-1932.
9. Bachmaier, K., Neu, N., de la Maza, L.M., Pal, S., Hessel, A., and Penninger, J.M. 1999. Chlamydia infections and heart disease linked through antigenic mimicry. Science 283:1335-1339.
10. Bowles, N.E., Richardson, P.J., Olse, E.G., and Archard, L.C. 1986. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1:1120-1123.
11. Brown, C.A. andO'Connell, J.B. 1995. Myocarditis and idiopathic dilated cardiomyopathy. Am. J. Med. 99:309-314.
12. Caforio, A.L., Goldman, J.H., Haven., A.J., Baig, K.M., and McKenna, W.J. 1996. Evidence for autoimmunity to myosin and other heartspecific autoantigens in patientswith dilated cardiomyopathy and their relatives. Int. J. Cardiol. 54:157-163.
13. Caforio, A.L., Mahon, N.J., and McKenna, W.J. 2001. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 34:199-204.
14. Cameron-Wilson, C.L., Zhang, H., Zhang, F., Buluwela, L., Muir, P., and Archard, L.C. 2002. A vector with transcriptional terminators increases efficiency of cloning of an RNA virus by reverse transcription long polymerase chain reaction. J. Mol. Microbiol. Biotechnol. 4:127-131.
15. Chapman, N.M., Tu, Z., Tracy, S., and Gauntt, C.J. 1994. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: Its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch. Virol. 135:115-130.
16. Chiale, P.A., Ferrari, I., Mahler, E., Vallazza, M.A., Elizari, M.V., Rosenbaum, M.B., and Levin, M.J. 2001. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103:1765-1771.
17. Cihakova, D. and Rose, N.R. 2008. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 99:95-114.
18. Cihakova, D., Barin, J.G., Afanasyeva, M., Kimura, M., Fairweather, D., Berg, M., Talor, M.V., Baldeviano, G.C., Frisancho, S., Gabrielson, K., Bedja, D., and Rose, N.R. 2008. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am. J. Pathol. 172:1195-1208.
19. Cooper, L.T. Jr. 2009. Myocarditis.N.Engl. J. Med. 360:1526-1538.
20. Cornell, C.T., Kiosses, W.B., Harkin, S., and Whitton, J.L. 2007. Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I. J. Virol. 81:6785-6797.
21. Coronado, M.J., Brandt, J.E., Kim, E., Bucek, A., Bedja, D., Abston, E.D., Shin, J., Gabrielson, K.L., Mitzner, W., and Fairweather, D. 2012. Testosterone and interleukin-1beta increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Am. J. Physiol. Heart Circ. Physiol. 302:H1726-H1736.
22. Cunningham, M.W., Antone, S.M., Gulizia, J.M., McManus, B.M., Fischetti, V.A., and Gauntt, C.J. 1992. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc. Natl. Acad. Sci. U.S.A. 89:1320-1324.
23. Cunningham, M.W., Antone, S.M., Smart, M., Liu, R., and Kosanke, S. 1997. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect. Immun. 65:3913-3923.
24. Cunningham, M.W., Meissner, H.C., Heuser, J.S., Pietra, B.A., Kurahara, D.K., and Leung, D.Y. 1999. Anti-human cardiac myosin autoantibodies in Kawasaki syndrome. J. Immunol. 163:1060-1065.
25. Diederich, K.W., Eisele, I., Ried, T., Jaenicke, T., Lichter, P., andVosberg, H.P. 1989. Isolation and characterization of the complete human betamyosin heavy chain gene. Hum. Genet. 81:214-220.
26. Donermeyer, D.L., Beisel, K.W., Allen, P.M., Smith, S.C. 1995. Myocarditis-inducing epitope of myosin binds constitutively and stably to IAK on antigen presenting cells in the heart. J. Exp. Med. 182:1291-1300.
27. Dunn, J.J., Chapman, N.M., Tracy, S., and Romero, J.R. 2000. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: Localization to the 5_ nontranslated region. J. Virol. 74:4787-4794.
28. Elamm, C., Fairweather, D., and Cooper, L.T. 2012. Pathogenesis and diagnosis of myocarditis. Heart 98:835-840.
29. Ellis, N.M.J., Li, Y., Fischetti, V.A., and Cunningham, M.W. 2005. T cell mimicry and epitope specificity of crossreactive T cell clones from rheumatic heart disease. J. Immunol. 175:5448-5456.
30. Ellis, N.M., Kurahara, D.K., Vohra, H., Mascaro-Blanco, A., Erdem, G., Adderson, E.E., Veasy, L.G., Stoner, J.A., Tam, E., Hill, H.R., Yamaga, K., and Cunningham, M.W. 2010. Priming the immune system for heart disease: A perspective on group A streptococci. J. Infect. Dis. 202:1059-1067.
31. Eriksson, U., Kurrer, M.O., Sebald, W., Brombacher, F., and Kopf, M. 2001. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: Induction by IL-12 and protection by IFN-gamma. J. Immunol. 167:5464-5469.
32. Eriksson, U., Kurrer, M.O., Schmitz, N., Marsch, S.C., Fontana, A., Eugster, H.P., and Kopf, M. 2003. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 107:320-325.
33. Fae, K.C., da Silva, D.D., Oshiro, S.E., Tanaka, A.C., Pomerantzeff, P.M., Douay, C., Charron, D., Toubert, A., Cunningham, M.W., Kalil, J., and Guilherme, L. 2006. Mimicry in recognition of cardiac myosin peptides by heartintralesional T cell clones from rheumatic heart disease. J. Immunol. 176:5662-5670.
34. Fairweather, D., and Rose, N.R. 2004. Models of coxsackievirus B3-induced myocarditis: Recent advances. Drug Discov. Today: Disease Models 1:381-386.
35. Fairweather, D. and Rose, N.R. 2007. Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicity. Methods 41:118-122.
36. Fairweather, D., Kaya, Z., Shellam, G.R., Lawson, C.M., and Rose, N.R. 2001. From infection to autoimmunity. J. Autoimmun. 16:175-186.
37. Fairweather, D., Yusung, S., Frisancho, S, Barrett, M., Gatewood, S., Steele, R., Rose, N.R. 2003. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J. Immunol. 170:4731-4737.
38. Fairweather, D., Frisancho-Kiss, S., Yusung, S.A., Barrett, M.A., Davis, S.E., Gatewood, S.J., Njoku, D.B., and Rose, N.R. 2004a. Interferongamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am. J. Pathol. 165:1883-1894.
39. Fairweather, D., Afanasyeva, D.M., and Rose, N.R. 2004b. Cellular immunity: A role for cytokines. In Handbook of Systemic Autoimmune Diseases: The Heart in Systemic Autoimmune Diseases (A. Doria and P. Pauletto, eds.) pp. 3-17. Elsevier Science, Amsterdam.
40. Fairweather, D., Frisancho-Kiss, S., Yusung, S.A., Barrett, M.A., Davis, S.E., Steele, R.A., Gatewood, S.J., and Rose, N.R. 2005. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J. Immunol. 174:261-269.
41. Fairweather, D., Stafford, K.A., and Sung, Y.K. 2012. Update on coxsackievirusB3 myocarditis. Curr. Opin. Rheumatol. 24:401-407.
42. Felker, G.M., Hu, W., Hare, J.M., Hruban, R.H., Baughman, K.L., and Kasper, E.K. 1999. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine 78:270-283.
43. Feuer, R., Mena, I., Pagarigan, R., Slifka, M.K., and Whitton, J.L. 2002. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76:4430-4440.
44. Fischetti, V.A., Jones, K.F., Manjula, B.N., and Scott, J.R. 1984. Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcalderived M protein. J. Exp. Med. 159:1083-1095.
45. Fong, I. 2003. Infections and the Cardiovascular System: New perspectives. Plenum Publishers, New York.
46. Frisancho-Kiss, S., Davis, S.E., Nyland, J.F., Frisancho, J.A., Cihakova, D., Barrett, M.A., Rose, N.R., and Fairweather, D. 2007. Cutting edge: Cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J. Immunol. 178:6710-6714.
47. Frisancho-Kiss, S., Coronado, M.J., Frisancho, J.A., Lau, V.M., Rose, N.R., Klein, S.L., and Fairweather, D. 2009. Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav. Immun. 23:649-657.
48. Fuse, K., Chan, G., Liu, Y., Gudgeon, P., Husain, M., Chen, M., Yeh,W.C., Akira, S., and Liu, P.P. 2005. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112:2276-2285.
49. Galvin, J.E., Hemric, M.E., Ward, K., and Cunningham, M.W. 2000. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J. Clin. Invest. 106:217-224.
50. Galvin, J.E., Hemric, M.E., Kosanke, S.D., Factor, S.M., Quinn, A., and Cunningham, M.W. 2002. Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am. J. Pathol. 160:297-306.
51. Guilherme, L., Kalil, J., and Cunningham, M. 2006. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39:31-39.
52. Guthrie, M., Lodge, P.A., and Huber, S.A. 1984. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3inBalb/cmice ismediated by Lyt 2 + cytolytic lymphocytes. Cell. Immunol. 88:558-567.
53. Hanawa, H., Tsuchida, M., Matsumoto, Y., Watanabe, H., Abo, T., Sekikawa, H., Kodama, M., Zhang, S., Izumi, T., and Shibata, A. 1993. Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis: Their similarity to extrathymic T cells in mice and the site of proliferation. J. Immunol. 150:5682-5695.
54. Henke, A., Huber, S., Stelzner, A., and Whitton, J.L. 1995. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69:6720-6728.
55. Herskowitz, A., Wolfgram, L.J., Rose, N.R., and Beisel, K.W. 1987. Coxsackievirus B3 murine myocarditis: A pathologic spectrum of myocarditis in genetically defined inbred strains. J. Am. Coll. Cardiol. 9:1311-1319.
56. Horwitz, M.S., La Cava, A., Fine, C., Rodriguez, E., Ilic, A., and Sarvetnick, N. 2000. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat. Med. 6:693-697.
57. Huber, S.A. 1997a. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab. Invest. 76:691-701.
58. Huber, S.A. 1997b. Autoimmunity in myocarditis: Relevance of animal models. Clin. Immunol. Immunopathol. 83:93-102.
59. Huber, S.A. 2005. Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: Role for CD1d. Med. Microbiol. Immunol. 194:121-127.
60. Huber, S.A. 2009. Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis. Immunology 127:567-576.
61. Huber, S.A. and Cunningham, M.W. 1996. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis. J. Immunol. 156:3528-3534.
62. Huber, S.A. and Pfaeffle, B. 1994. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J. Virol. 68:5126-5132.
63. Huber, S.A. and Sartini, D. 2005a. Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis. J. Virol. 79:2659-2665.
64. Huber, S.A. and Sartini, D. 2005b. T cells expressing the Vgamma1 T-cell receptor enhance virusneutralizing antibody response during coxsackievirus B3 infection of BALB/c mice: Differences in male and female mice. Viral. Immunol. 18:730-739.
65. Huber, S.A., Moraska, A., and Cunningham, M. 1994. Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci. Proc. Natl. Acad. Sci. U.S.A. 91:5543-5547.
66. Huber, S.A., Gauntt, C.J., and Sakkinen, P. 1998. Enteroviruses and myocarditis: Viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv. Virus Res. 51:35-80.
67. Huber, S.A., Sartini, D., and Exley, M. 2003. Role of CD1d in coxsackievirus B3-induced myocarditis. J. Immunol. 170:3147-3153.
68. Inomata, T., Hanawa, H.,Miyanishi, T., Yajima, E., Nakayama, S.,Maita, T.,Kodama,M., Izumi, T., Shibata, A., and Abo, T. 1995. Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circ. Res. 76:726-733.
69. Jaenicke, T., Diederich, K.W., Haas, W., Schleich, J., Lichter, P., Pfordt, M., Bach, A., and Vosberg, H.P. 1990. Complete sequence of human β myosin. Genomics 8:194-207.
70. Kandolf, R. and Hofschneider, P.H. 1985. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 82:4818-4822.
71. Karp, C.L., Grupe, A., Schadt, E., Ewart, S.L., Keane-Moore, M., Cuomo, P.J., K̈ohl, J., Wahl, L., Kuperman, D., Germer, S., Aud, D., Peltz, G., and Wills-Karp, M. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1:221-226.
72. Katus, H.A., Remppis, A., Neumann, F.J., Scheffold, T., Diederich, K.W., Vinar, G., Noe, A., Matern, G., and Kuebler, W. 1991. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83:902-912.
73. Kaya, Z., Dohmen, K.M.,Wang, Y., Schlichting, J., Afanasyeva, M., Leuschner, F., and Rose, N.R. 2002. Cutting edge: A critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J. Immunol. 168:1552-1556.
74. Kemball, C.C., Harkins, S., Whitmire, J.K., Flynn, C.T., Feuer, R., and Whitton, J.L. 2009. Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog. 5:e1000618.
75. Kindermann, I., Kindermann, M., Kandolf, R., Klingel, K.,B̈ultmann, B.,M̈uller, T., Lindinger, A., and B̈ohm, M. 2008. Predictors of outcome in patients with suspected myocarditis. Circulation 118:639-648.
76. Knowlton, K.U., Jeon, E.S., Berkley, N., Wessely, R., and Huber, S. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70:7811-7818.
77. Kodama,M., Matsumoto,Y., Fujiwara, M.,Masani, F., Izumi, T., and Shibata, A. 1990. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 57:250-262.
78. Kohno, K., Takagaki, Y., Nakajima, Y., and Izumi, T. 2000. Advantage of recombinant technology for the identification of cardiac myosin epitope of severe autoimmune myocarditis in Lewis rats. Jpn. Heart J. 41:67-77.
79. Kohno, K., Takagaki, Y., Aoyama, N., Yokoyama, H., Takehana, H., and Izumi, T. 2001. A peptide fragment of beta cardiac myosin heavy chain (beta-CMHC) can provoke autoimmune myocarditis as well as the corresponding alpha cardiac myosin heavy chain (alpha-CMHC) fragment. Autoimmunity 34:177-185.
80. Krisher, K. and Cunningham, M.W. 1985. Myosin: A link between streptococci and heart. Science 227:413-415.
81. Kuhl, U., Pauschinger, M., Noutsias, M., Seeberg, B., Bock, T., Lassner, D., Poller, W., Kandolf, R., and Schultheiss, H.P. 2005. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with idiopathic left ventricular dysfunction. Circulation 111:887-893.
82. Lauer, B., Padberg, K., Schultheiss, H.P., and Strauer, B.E. 1994. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J. Am. Coll. Cardiol. 23:146-153.
83. Lauer, B., Schannwell, M., K̈uhl, U., Strauer, B.E., and Schultheiss, H.P. 2000. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J. Am. Coll. Cardiol. 35:11-18.
84. Lawson, C.M. 2000. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol. Life Sci. 57:552-560.
85. Lee, C., Maull, E., Chapman, N., Tracy, S., Wood, J., and Gauntt, C. 1997. Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs. Virus Res. 50:225-235.
86. Li, Y., Heuser, J.S., Kosanke, S.D., Hemric, M., and Cunningham, M.W. 2004a. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J. Immunol. 172:3225-3234.
87. Li, Y., Heuser, J.S., Kosanke, S.D., Hemric, M., and Cunningham, M.W. 2004b. Protection against experimental autoimmune myocarditis is mediated by IL-10 producing T cells that are controlled by dendritic cells. Am. J. Pathol. 167:5-15.
88. Li, Y., Heuser, J.S., Cunningham, L.C., Kosanke, S.D., and Cunningham, M.W. 2006. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J. Immunol. 177:8234-8240.
89. Lodge, P.A., Herzum, M., Olszewski, J., and Huber, S.A. 1987. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am. J. Pathol. 128:455-463.
90. Lyden, D.,Olszewski, J., andHuber, S. 1987a. Variation in susceptibility of Balb/c mice to coxsackievirus group B type 3-induced myocarditis with age. Cell Immunol. 105:332-339.
91. Lyden, D.C., Olszewski, J., Feran, M., Job, L.P., and Huber, S.A. 1987b. Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am. J. Pathol. 126:432-438.
92. Maisch, B., Trostel-Soeder, R., Stechemesser, E., Berg, P.A., and Kochsiek, K. 1982. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin. Exp. Immunol. 48:533-545.
93. Maisch, B., Deeg, P., Liebau, G., and Kochsiek, K. 1983. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am. J. Cardiol. 52:1072-1078.
94. Mascaro-Blanco, A., Alvarez, K., Yu, X., Lindenfeld, J., Olansky, L., Lyons, T., Duvall, D., Heuser, J.S., Gosmanova, A., Rubenstein, C.J.,Cooper, L.T.,Kem,D.C., andCunningham, M.W. 2008. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity 41:442-453.
95. Matsumori, A. 2005. Hepatitis C virus infection and cardiomyopathies. Circ. Res. 96:144-147.
96. Matsumori, A., Shimada, T., Chapman, N.M., Tracy, S.M., and Mason, J.W. 2006. Myocarditis and heart failure associated with hepatitis C virus infection. J. Card. Fail. 12:293-298.
97. McManus, B.M., Chow, L.H., Wilson, J.E., Anderson, D.R., Gulizia, J.M., Gauntt, C.J., Klingel, K.E., Beisel, K.W., and Kandolf, R. 1993. Direct myocardial injury by enterovirus: A central role in the evolution of murine myocarditis. Clin. Immunol. Immunopathol. 68:159-169.
98. McNamara, D.M., Starling, R.C., Cooper, L.T., Boehmer, J.P., Mather, P.J., Janosko, K.M., Gorcsan, J. 3rd, Kip, K.E., Dec, G.W., and IMAC Investigators. 2011. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: Results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J. Am. Coll. Cardiol. 58:1112-1118.
99. Moseley, T.A., Haudenschild, D.R., Rose, L., and Reddi, A.H. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155-174.
100. Murphy, K.P.T. and Walport, M. 2008. Janeway's Immunobiology. 7th Edition. Garland Science, New York. Neu, N., Rose, N.R., Beisel, K.W., Herskowitz, A., Gurri-Glass, G., and Craig, S.W. 1987a. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 139:3630-3636.
101. Neu, N., Beisel, K.W., Traystman, M.D., Rose, N.R., and Craig, S.W. 1987b. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to coxsackievirus B3 induced myocarditis. J. Immunol. 138:2488-2492.
102. Neumann, D.A., Burek, C.L., Baughman, K.L., Rose, N.R., and Herskowitz, A. 1990. Circulating heart reactive antibodies in patients with myocarditis or cardiomyopathy. J. Am. Coll. Cardiol. 16:839-846.
103. Onyimba, J.A., Coronado, M.J., Garton, A.E., Kim, J.B., Bucek, A., Bedja, D., Gabrielson, K.L., Guilarte, T.R., and Fairweather, D. 2011. The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice. Biol. Sex. Differ. 2:2.
104. Opavsky, M.A., Penninger, J., Aitken, K., Wen, W.H., Dawood, F., Mak, T., and Liu, P. 1999. Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circ. Res. 85:551-558.
105. Opavsky, M.A., Martino, T., Rabinovitch, M., Penninger, J., Richardson, C., Petric, M., Trinidad, C., Butcher, L., Chan, J., and Liu, P.P. 2002. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J. Clin. Invest. 109:1561-1569.
106. Palmenberg, A.C. 1988. Molecular Aspects of Picornavirus Infection and Detection. American Society for Microbiology, Washington, D.C.
107. Penninger, J.M., Neu, N., Timms, E., Wallace, V.A., Koh, D.R., Kishihara, K., Pummerer, C., and Mak, T.W. 1993. Induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules. J. Exp. Med. 178:1837-1842.
108. Penninger, J.M., Neu, N., and Bachmaier, K. 1996. A genetic map of autoimmune heart disease. Immunologist 4:131-141.
109. Poffenberger,M.C., Straka, N., ElWarry, N., Fang, D., Shanina, I., and Horwitz, M.S. 2009. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis. PLoS One 4:e6207.
110. Pummerer, C.L., Luze, K., Gr̈assl, G., Bachmaier, K., Offner, F., Burrell, S.K., Lenz, D.M., Zamborelli, T.J., Penninger, J.M., and Neu, N. 1996. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J. Clin. Invest. 97:2057-2062.
111. Quinn, A., Kosanke, S., Fischetti, V.A., Factor, S.M., and Cunningham, M.W. 2001. Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect. Immun. 69:4072-4078.
112. Quinn-Laquer, B.K., Kennedy, J.E., Wei, S.J., and Beisel, K.W. 1992. Characterization of the allelic differences in the mouse cardiac alphamyosin heavy chain coding sequence. Genomics 13:176-188.
113. Roberts, S., Kosanke, S., Terrence Dunn, S., Jankelow, D., Duran, C.M., and Cunningham, M.W. 2001. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. J. Infect. Dis. 183:507-511.
114. Rose, N.R., Wolfgram, L.J., Herskowitz, A., and Beisel, K.W. 1986. Postinfectious autoimmunity: Two distinct phases of coxsackievirus B3-induced myocarditis. Ann. N.Y. Acad. Sci. 475:146-156.
115. Rose, N.R., Herskowitz, A., and Neumann, D.A. 1993. Autoimmunity in myocarditis: Models and mechanisms. Clin. Immunol. Immunopathol. 68:95-99.
116. Saez, L.J., Gianola, K.M., McNally, E.M., Feghali, R., Eddy, R., Shows, T.B., and Leinwand, L.A. 1987. Human cardiac myosin heavy chain genes and their linkage in the genome. Nucleic Acids Res. 15:5443-5459.
117. Slifka, M.K., Pagarigan, R., Mena, I., Feuer, R., andWhitton, J.L. 2001. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J. Virol. 75:2377-2387.
118. Smith, S.C. and Allen, P.M. 1991. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 147:2141-2147.
119. Smith, S.C. and Allen, P.M. 1992a. Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc. Natl. Acad. Sci. U.S.A. 89:9131-9135.
120. Smith, S.C. and Allen, P.M. 1992b. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ. Res. 70:856-863.
121. Smith, S.C., Ladenson, J.H.,Mason, J.W., and Jaffe, A.S. 1997. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95:163-168.
122. Sonderegger, I.,Rohn, T.A.,Kurrer, M.O., Iezzi,G., Zou, Y., Kastelein, R.A., Bachmann, M.F., and Kopf,M. 2006. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur. J. Immunol. 36:2849-2856.
123. Stavrakis, S.,Yu, X., Patterson, E.,Huang, S., Hamlett, S.R.,Chalmers, L., Pappy,R., Cunningham, M.W.,Morshed, S.A., Davies, T.F., Lazzara, R., and Kem, D.C. 2009. Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J. Am. Coll. Cardiol. 54:1309-1316.
124. Tobacman, L.S. and Adelstein, R.S. 1984. Enzymatic comparisons between light chain isozymes of human cardiac myosin subfragment-1. J. Biol. Chem. 259:11226-11230.
125. Towbin, J.A., Bowles,K.R., andBowles, N.E. 1999. Etiologies of cardiomyopathy and heart failure. Nat. Med. 5:766-767.
126. Tsueng, G., Tabor-Godwin, J.M., Gopal, A., Ruller, C.M., Deline, S., An, N., Frausto, R.F., Milner, R., Crocker, S.J., Whitton, J.L., and Feuer, R. 2011. Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells. J. Virol. 85:5718-5732.
127. Wang, J., Okazaki, I.M., Yoshida, T., Chikuma, S., Kato, Y., Nakaki, F., Hiai, H., Honjo, T., and Okazaki, T. 2010. PD-1 deficiency results in the development of fatal myocarditis in MRL mice. Int. Immunol. 22:443-452.
128. Wegmann, K.W., Zhao, W., Griffin, A.C., and Hickey, W.F. 1994. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. J. Immunol. 153:892-900.
129. Wessely, R., Klingel, K., Knowlton, K.U., and Kandolf, R. 2001. Cardioselective infectionwith coxsackievirus B3 requires intact type I interferon signaling: Implications for mortality and early viral replication. Circulation 103:756-761.
130. Wolfgram, L.J., Beisel, K.W., Herskowitz, A., and Rose, N.R. 1986. Variations in the susceptibility to coxsackievirus B3-ionduced myocarditis among different strains of mice. J. Immunol. 136:1846-1852.
131. Woodruff, J.F. 1980. Viral myocarditis: A review. Am. J. Pathol. 101:425-466.
132. Wynn, T.A. and Ramalingam, T.R. 2012. Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat. Med. 18:1028-1040
133. Zabriskie, J.B. 1985. Rheumatic fever: The interplay between host, genetics and microbe. Circulation 71:1077-1086.